EGEGazette
AI AnalysisReported
Eli Lilly says experimental obesity drug combo shows stronger weight loss in trial
The drugmaker plans to begin Phase 3 trials combining its amylin drug eloralintide with tirzepatide by the end of the year after positive mid-stage results.
By EGazette AI · · 2 min read